Online Intervention to Prevent Perinatal Depression and Promote Breastfeeding

University of Illinois

Status

Completed

Conditions

Breastfeeding

Depression

Treatments

Behavioral: Sunnyside Plus

Behavioral: Sunnyside

Study type

Interventional

Funder types

Other

Identifiers

NCT04128202

2019-0519

Details and patient eligibility

About

"SunnysidePlus" will functionally integrate a web based intervention targeting skills to promote and support breastfeeding, manage mood,and prevent depression. Sunnyside Plus will build upon the previously tested "Sunnyside" intervention which targeted skills to manage mood through an interactive website with didactic material and tools. Women in weeks 20-28 of their pregnancy will be randomized to receive either Sunnyside Plus or Sunnyside. The Sunnyside intervention will consist of 6 weeks of online lessons during pregnancy and booster sessions at 2 weeks, 4 weeks, and 6 weeks postpartum. Sunnyside Plus will include additional education and support to improve breastfeeding outcomes. Breastfeeding education and skills will be provided during the 6 weeks of online lessons during pregnancy. Breastfeeding support will continue through 6 weeks postpartum. This postpartum support will involve weekly online lessons, text support, and video support calls with a Lactation Educator provided on an as-needed basis. SunnysidePlus has the potential to provide a novel paradigm for improving breastfeeding outcomes and preventing depression; one that is accessible, highly scalable and cost-effective.

Enrollment

22 patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Female
Black or African American
18 years and older
Pregnant and between 20 and 28 weeks gestation
Intend to breastfeed their child
Have a score of 5-14 on the Patient Health Questionnaire-8 (PHQ-8)
Have access to a broadband internet connection
Are able to read and speak English

Exclusion criteria

Are pregnant with multiples
Have visual, hearing, voice, or motor impairment that would prevent completion of study procedures
Diagnosed with a major depressive episode, psychotic disorder, bipolar disorder, dissociative disorder, substance use disorder or other diagnosis for which participation in this trial is either inappropriate or dangerous based on self-report
Are currently receiving treatment (medication or psychotherapy),have an intention to resume antidepressant medication after delivery (i.e., women who discontinued their medication during pregnancy).